Search Results for: "Universal Cells"

Startup Clade from CRISPR Therapeutics founder pursues cloaked stem cells for cancer therapy

Chad-Cowan CRISPR Therapeutics

CRISPR Therapeutics has been pursuing the idea of using gene-editing to make universally compatible stem cells for some time, but there’s an new development in this space. The potential here is big. What if you could make cloaked stem cells that could be used to produce cellular therapies that could be given to most patients …

Startup Clade from CRISPR Therapeutics founder pursues cloaked stem cells for cancer therapy Read More »

Recommended reads: Bee brain, COVID, from Russia with stem cells, pubs

Reprogramming-roadmap-reveals-route-to-human-induced-trophoblast-stem-cells

Reading to them was one of my favorite things to do with my kids when they were little, but it’s a long way from Goodnight Moon to this week’s list of recommended reads, although “bee brain” may have got their attention. Please take a minute to complete our The Niche reader survey for a chance …

Recommended reads: Bee brain, COVID, from Russia with stem cells, pubs Read More »

Recommended regenerative medicine reads plus COVID-19 stem cell hype

Universal-Cells

Despite the COVID-19 pandemic there are still some research things we can do including data analysis as well as reading new papers and media articles on science, including regenerative medicine. If the weather’s good and you have wi-fi (or you print articles still on paper) you can even do this out in the fresh air …

Recommended regenerative medicine reads plus COVID-19 stem cell hype Read More »

Quick Q&A with ViaCyte CEO on CRISPR-stem cell work

VC-01-post-implant-final1-e1503703572933, viacyte

We heard this week about the encouraging news of a new CRISPR-stem cell collaboration between stem cell biotech ViaCyte and CRISPR Therapeutics. The goal of the team is to make genetically engineered pancreatic derivatives from stem cells that would have a unique immune stealthiness. If such an approach was successful, patients would not need to …

Quick Q&A with ViaCyte CEO on CRISPR-stem cell work Read More »